Roberts, P. M. M., Arrowsmith, D. E., Lloyd, A. V. C., and Monk-Jones, M. E. (1972) . Archives of Disease in Childhood, 47, 631. Effect of folic acid treatment on premature infants. After finding that a group of premature infants became extremely deficient in folate after 3 months of age, a comparable group of premature infants was treated with 100 ,g folic acid given orally daily starting at 28 days of age. Haemoglobin and red cell folate levels were followed in this group of infants and were compared with those in the group originally studied.
In both groups Hb levels fell from birth to the lowest levels at about 2 months of age. In the treated group mean Hb at this age was 10 -3 g/100 ml, whereas in the untreated group it fell to 8 3 g/100 ml. After 2 months of age the mean Hb level rose at the same rate of 0*023 g/100 ml per day in both groups. The treated group maintained a mean Hb level 2 27 g/100 ml higher than the untreated group at every age from 3 to 6 months.
Red cell folate values in the untreated group showed a steady fall up to 6 months, but the treated group showed a marked rise, starting on average 10 days after the giving of folate supplements. Red cell folate levels of this treated group remained well above the levels found in the untreated group until at least 6 months of age.
Patients and Methods
The babies were born at 2 maternity hospitals in the same region, designated hospital A and hospital B. The 2 hospitals served populations of similar social status, the hospitals being about 3 miles apart. The 2 groups of premature babies were compared for the mean and standard deviation of birthweights. The mean weight was 2036 g in group A (SD = 460 g) and 1943 g in group B (SD = 391); there was no statistically significant difference between the 2 groups, the 't' test being 1 2, which is not significant.
Group B consisted of 44 babies who had been given a diet which was later found to be folate deficient (Roberts et al., 1969) . The second group of 66 babies from hospital A were mainly bottle-fed, initially with a proprietary preparation of powdered milk and later with full-cream powdered milk; a few were breast-fed.
In addition, this group all had supplements of 100 ,ug folic acid orally daily from 28 days of age until approximately the sixth month. Both groups had iron and vitamins A, D, and C from the 28th day. Mixed feeding was introduced at the same time in both groups of infants, when they weighed 5000 g. Thus the main difference in the 2 groups, apart from folic acid supplements in group A, was that group B were given boiled expressed human breast milk until mixed feeding started, whereas group B was given powdered milk.
Antenatally the mothers of the babies in group A were given 0 4 mg folic acid daily and those in group B were given 3*4 mg folic acid daily.
The investigations were carried out when the babies returned to the premature baby follow-up clinic at intervals until 6 months of age.
Estimations of Hb, packed cell volume, and red cell folate were all carried out on capillary blood samples in the same laboratory and by the same methods as previously described (Roberts et al., 1969) .
Haemoglobin Results
The mean Hb levels for the age ranges shown in Table I are plotted at the midpoint of the age range (Fig. 1) . The straight lines drawn are the 'regression lines' (lines of best fit) computed from the individual levels and ages for days (1-29) and (80-180). Table II gives the rates of fall during the first period and of rise during the second period together with their significance.
Group A started at a significantly higher mean level than B (Table I , column 1) but fell at a significantly greater rate so that for the 20 days before treatment the mean level of A was below the mean level of B, but not significantly so (Table I , columns 2 and 3). In the first 10 days after starting treat- 11-9 12-7 13-4 Range 120-23*6 126-19*6 9-7-16-2 93-13*8 8-2-13-2 8-2-11-9 96-12*2 10-5-13-8 11-2-14-2 124-14-6 No. of Red Cell Folate Results In both groups of infants the red cell folate levels started very high at birth (Table III and Fig. 2) . The mean value during the first 10 days of age in group A was 807 ng/ml, with a range of 380-1110 ng/ml, and in group B it was 563 ng/ml, with a range of 230-1250 ng/ml. During the first 4 weeks of life the levels fell steeply and the curves are roughly parallel. After this age the red cell folate levels continued to fall consistently but less steeply till 6 months of age in group B. In group A, however, after 30 days the curve levelled out and then the folate content rose fairly sharply till the third month of age when in many babies it was even higher than the mean level at birth. From 80 days the group A mean red cell folate level fell gradually till it was nearly 500 ng/ml as compared with the mean level of 103 ng/ml in group B between 5 and 6 months of age. Discussion Neonatal Hb levels are very variable due to 2 main factors: the transfusion of cells from the placenta and haemoconcentration (De Gruchy, 1970) . The time elapsing between birth and clamping the cord often differs according to the practice in different hospitals and this may explain the difference in Hb levels between group A and group B during the first 10 days of life.
A recent review in this journal (Hoffbrand, 1970 ) discusses a number of precipitating causes for folate deficiency in premature infants, for example infection and haemolytic anaemia. None of the infants we studied suffered from these complications. (Sullivan, Luhby, and Streiff, 1966) .
It was not known whether newborn infants adequately absorb folic acid given by mouth (Hoffbrand, 1970) . The results of the treated infants clearly showed that the folate supplements of 100 ,ug daily were absorbed and the folate incorporated into the red cells. Hoffbrand (1970) also mentioned some workers who claim that prophylactic treatment with folic acid had no influence on the Hb levels of premature infants. One of these (Burland, Simpson, and Lord, 1971) compared 2 groups of low birthweight infants, one group treated with 100 ,ug folic acid intramuscularly on alternate days for 28 days during the first 5 weeks of life, the other group untreated.
Both groups were followed up to 9 months of age and comparisons were made of Hb, red cell count, and haematological indices in the 2 groups. The conclusion reached was that though there was a significant increase in the serum and red cell folate levels in the treated group, there was no subsequent significant difference in the haematological indices in the 2 groups.
As We therefore conclude that small doses of folic acid by mouth are absorbed by infants and incorporated into their red cells to give high normal values for red cell folate. It seems possible that the anaemia in the untreated infants was partly consequent upon their low intake of folate and the resulting deficient stores shown by their subnormal red cell folate levels.
Maintaining adequate folate stores by supplementing premature babies with folic acid may thus eliminate one of the factors contributing to the so-called anaemia of prematurity. There is however a need for a double-blind trial in this field before any firm conclusions can be made.
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